Mogamulizumab in patients with mycosis fungoides/Sézary syndrome: Translational data results from the MOGA-2MG-Q4W Phase 2, open-label, multicenter, single-arm study assessing a 4-weekly dosing schedule
Year: 2025
Type: article
Source: European Journal of Cancer
Authors: Christiane Querfeld, Julia Scarisbrick, Oleg Akilov, Martine Bagot, Raul Cordoba, Richard Cowan, Alejandro Martıń Garcıá-Sancho, Larisa J. Geskin, Auris O. Huen, Stephen Morris, Pablo L. Ortiz-Romero, Lauren C. Pinter-Brown, Ramon M. Pujol, Pietro Quaglino, Nakhle S. Saba, Yi Liu, Henry Zhao, Payal Arora, Youn H. Kim
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415228143